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Overview
•

What is Contrast Enhanced Ultrasound (CEUS)?

•

Overview of contrast agents

•

Brief discussion of physics

•

Technical considerations

•

Benefits and limitations compared to other modalities

•

Current indications for CEUS according to the ACR

•

Contrast Enhanced Ultrasound in breast imaging

What is Contrast Enhanced Ultrasound
(CEUS)?
•

Advanced form of ultrasound in which
images are acquired:
● Using injected IV microbubble contrast
agents
● With technology optimized to visualize
the contrast agents

Focal Nodular Hyperplasia,
Case courtesy of Dr Jan Gerstenmaier, Radiopaedia.org

Ultrasound Contrast Agents
•

Free Gas Bubbles

•

Encapsulated Bubbles
● Blood-pool agents
● Selective-uptake agents

Free Gas Bubbles
•

First used to enhance the blood echo in 1968
● Saline was agitated into the left ventricle during an
echocardiogram
● Strong echoes were seen within the lumen of the aorta
● Echoes originated from free bubbles of air that came out of solution
either during agitation or at time of catheter injection

Free Gas Bubbles
•

"Shaken saline"
● Early use of agitated saline
● Saline injected rapidly from one syringe
into another so traces of air were
incorporated as bubbles
● Used to identify right-to-left intracardiac
shunts
● Seen as echoes in the left atrium or left
ventricle following IV injection

● Major issues with this method
● Size of bubbles produced could not be
controlled
● Complications including paradoxical
cerebral emboli, infarcts, and death
Echocardiography, Volume: 32, Issue: 11, Pages: 1707-1719, First published: 07 August 2015, DOI: (10.1111/
echo.13035)

Free Gas Bubbles
•

Applications as a contrast agent are
limited to the heart
● Rarely used outside of echo
examinations for intracardiac shunts

•

Fundamental limitations of bubbles
produced this way
● Large size means bubbles are effectively
filtered by the lungs
● Unstable and go back to solution on the
order of a second

Curitosy of Southwest Journal of Pulmonary and Critical Care
https://www.swjpcc.com/critical-care/2014/8/4/ultrasound-for-criticalcare-physicians-where-did-the-bubble.html

Ultrasound contrast agent
•

Ideal contrast agent
● Needs to be stable enough to survive passage through the cardiovascular and
pulmonary circulation
● Small enough to allow for effective intravenous administration
● Produce effect distinguishable from surrounding tissues

Encapsulated Bubbles
•

First developed in the 1980s

•

Contrast agent used in both radiology and cardiology studies

•

Approved in U.S. in 2016 by FDA for liver diagnosis in adults and children

Encapsulated Bubbles
•

Composed of:
● Stabilizing thin shell layer of a flexible, biocompatible
material
● Typically a lipid
● Proteins and polymers are also used

● Bubble composed of small spheres of a high molecular
weight gas with a low solubility in blood
● i.e. Fluorocarbons

Greis C. Ultrasound contrast agents as markers of
vascularity and microcirculation. Clinical
hemorheology and microcirculation. 2009;43(1-2).

Encapsulated Bubbles
•

Encapsulated bubbles typically are 3-5 µm (slightly smaller than RBC)
● Due to this size, bubbles provide a pure intravascular contrast agent
● Small enough to cross capillary beds, but not so small as to pass into the interstitium
● Larger than molecules and particles used as contrast for CT and MRI which can diffuse
through fenestrated endothelium of blood vessels and into the interstitium
● Interstitial/parenchymal phase

•

Injected into a peripheral vein, just like other contrast agents

•

Typical dose contains on the order of 10 million bubbles
● Effect is to increase the echo from blood by a factor of 500-1000

Burns P. Contrast Agents for Ultrasound. In: Diagnostic
Ultrasound. 5th ed. Philadelphia, PA: Elsevier; 2018.

Types of Encapsulated
Bubbles
•

Blood-pool

•

Selective-Uptake agents
● Reticuloendothelial

Tinkov S. https://www.semanticscholar.org/paper/Development-ofUltrasound-Contrast-Agents-for-Drug-Tinkov/
53bee4b4742cc50f98251c15efcaf84761003c6a/figure/0.

Blood Pool Agents
•

Examples include:
● SonoVue/Lumason
● Definity/Luminity
● Optison

•

Same flow dynamics as blood itself

•

Ultimately metabolized from the blood
pool
● Trace shell material is reduced to
biocompatible elements already present
in the blood
● Fluorocarbon gas goes into solution in
blood and is ultimately excreted by the
lungs and liver

CEUS LI-RAD v2017 Core

Selective-Uptake Agents
•

Examples include:
● Levovist
● Sonazoid

•

Demarcate the distribution of Kupffer
cells
● "Late-phase" enhancement in liver
parenchyma after clearance from
vascular system
● Allows detection of Kupffer cell-poor lesions
such as mets
● Hypoenhancing in the "Late-phase"
● Tissues comprised of functioning liver will
have the same property as
surrounding parenchyma and disappear in the
"Late-phase"

Journal of Ultrasound in Medicine, Volume: 28, Issue: 4, Pages: 439-448, First
published: 01 April 2009, DOI: (10.7863/jum.2009.28.4.439)

Physics of CEUS
•

Exploit the behavior of microbubbles to provide information
on microcirculation
● High compressibility of the gas microbubble in comparison to
the virtual incompressibility of the surrounding tissue

•

Microbubbles of gas respond to the alternating high
pressure (compression phase) and low pressure (rarefaction
phase) cycles of the ultrasound wave by changing in
diameter
● Gas bubble compresses during positive pressure phase and
expands during the negative pressure phase

•

Oscillations are typically asymmetric as it is easier for gas
to expand than compress

Esner S. https://www.researchgate.net/figure/
Microbubble-interactions-with-ultrasound-A-Themicrobubble-diameter-changeswhen_fig5_236693080.

Physics of CEUS
•

Asymmetry of oscillations distorts the returning wave
● "Non-linear response"

•

Non-linearities appear as harmonics of the original
transmitted US frequency and can be seen on a
frequency spectrum

•

Oscillations can become even more complex at higher
pressures
● Increasing the non-linear properties

Burns P. Contrast Agents for Ultrasound. In: Diagnostic
Ultrasound. 5th ed. Philadelphia, PA: Elsevier; 2018.

Physics of CEUS
•

Bubbles have a natural oscillation frequency
(resonance) dependent on their size

•

When the driving pressure is matched to this
frequency the bubbles become extremely
efficient at translating sound energy into
scattered signals

Burns P. Contrast Agents for Ultrasound. In: Diagnostic
Ultrasound. 5th ed. Philadelphia, PA: Elsevier; 2018.

Physics of CEUS
•

Development of specialized multi-pulse sequences to
cancel tissue signals and emphasize signals from the
microbubbles

•

Example is Pulse Inversion Mode (PIM)
● Pair of pulses are sent sequentially along each scan line
● The second pulse is inverted in polarity from the first
● Returning echoes from the pair are summed
● Linear echoes will cancel out because they are completely out
of phase
● Non-linear echoes remain and are used for image formation

Burns P. Contrast Agents for Ultrasound. In: Diagnostic
Ultrasound. 5th ed. Philadelphia, PA: Elsevier; 2018.

Technical
Considerations

•

Imaging display

•

Contrast Phases

•

Mechanical Index (MI)

•

Bubble destruction

Technical
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Imaging display
•

●

•

Dual-image display format
Conventional B-mode low MI image and
bubble-only contrast image displayed side-byside

Able to overlay the contrast enhanced and
low MI fundamental B-mode image

FNH, Case courtesy of Dr Jan Gerstenmaier,
Radiopaedia.org

Technical
Considerations

•

Imaging display

•

Contrast Phases

•

Mechanical Index (MI)

•

Bubble destruction

Contrast Phases
•

Real-time evaluation of wash-in and
wash-out phases

•

Main diagnostic features
● Vasculature architecture (evaluated in
the early wash-in phase)
● Contrast enhancement of the lesion
compared to the adjacent tissue (time
course of wash-in and wash-out)

•

Multiple liver phases
● Arterial phase, Portal Venous Phase,
and Sinusoidal/Late Phase
● Can get a 4th Post-Vascular/Kupffer Cell
Phase when using a Selective-Uptake
contrast agent
Case courtesy of Dr Balint Botz , Radiopaedia.org, rID: 68865

"Wash-in" and "Wash-out"
•

Dynamic evaluation of "Wash-in"
can be both qualitative and
quantitative

•

Select region of interest and
measure progressive
enhancement from time of initial
bubble arrival, to peak
enhancement, and reduction in
enhancement ("Wash-out")
● Develop Time-intensity curve (TIC)

Pecere S, Holleran G, Ainora ME, et al. Usefulness of contrast-enhanced
ultrasound (CEUS) in Inflammatory Bowel Disease (IBD). Dig Liver Dis.
2018;50(8):761–767. doi:10.1016/j.dld.2018.03.023

Technical
Considerations

•

Imaging display

•

Contrast Phases

•

Mechanical Index (MI)

•

Bubble destruction

Mechanical Index
•

Estimated normalized peak negative
pressure to which tissue is exposed
● Attempt to measure part of an ultrasound
beam's bioeffects
● Inversely proportional to frequency of the beam

•

Low MI used for CEUS for 2 reasons:
1.
2.

Minimizes bubble destruction
Tissue harmonics are stronger when
a higher acoustic power is used

The impact of varying mechanical index on microbubble behaviour
(Lindner J et al. Curr Probl Cardiol (2002); 11; 454-519)

Technical
Considerations

•

Imaging display

•

Contrast Phases

•

Mechanical Index (MI)

•

Bubble destruction

Bubble destruction
•

Most often occurs from excessive or continuous
scanning in a single plane
● May mimic lesion wash-out

•

Can also occur if MI set too high

•

Can be used to operator's advantage

●
●

Free gas is a highly effective acoustic scatterer
Can evaluate tissue perfusion with intermittent
high MI induced destruction of bubbles and
observing replenishment ("triggered" or "interval
delay" imaging)

Case courtesy of Dr Balint Botz , Radiopaedia.org, rID: 72238

CEUS compared to other modalities
•

Permits real-time imaging and assessment of lesion perfusion

•

Safer contrast agent than other modalities
● Lack of cardio-,hepato-, and nephrotoxic effects
● Virtually no known adverse reactions

•

Can inject contrast multiple times during examinations if needed

•

Requires a higher level of expertise for optimal performance

Indications per Practice Parameter

Indications
•

Liver
● Focal lesion in a cirrhotic and noncirrhotic liver
● Vascularity

•

•

Endovascular aortic repair and
cerebrovascular assessment
Pancreas
● Pancreatic lesions/cysts

Bowel
● IBD

•

Kidney & bladder
● Voiding cystourethrography (VCUG) in peds
● Renal tumors and cystic lesions

•

•

Spleen
● Lesions & infarct

•

Scrotum
● Masses & infarct

•

Trauma
● Evaluation for solid organ injury

•

Intracavitary injection
● Fistula evaluation
● Sonosalpingography

•

Interventional guidance

CEUS and LI-RADS
•

Goal to establish findings consistent with traditional CT/MRI criteria for HCC
● Not intended to replace, but rather augment in situations where CT/MR inconclusive
● Most suitable for problem solving

•

CEUS LI-RADS is being developed for:
● Characterize occult nodules on precontrast gray-scale images
● Assess treatment response

CEUS differences specific to LI-RADS
•

Real-time imaging can eliminate possibility of arterial phase mistiming

•

Purely intravascular agent means there is true washout
● But no "capsule"

•

Ability to repeatedly bolus can permit more complete characterization of an
observation

•

Does not depict vascular pseudolesions
● i.e. arterioportal shunts

•

Permits characterization of a limited number of observations per exam

https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS/CEUS-LI-RADS-v2017

But what about Breast?

Breast Cancer
•

Excluding skin cancer, breast cancer is the most frequently diagnosed cancer
in American woman
● 2nd most common cause of cancer related death

•

Early diagnosis influences treatment and prognosis

•

False-positives in mammography may result in unnecessary biopsies

CEUS & Breast Cancer
•

Not much going on in the United States

•

Widespread usage and research on this topic in Asia
● Asian women typically have smaller, more dense breasts which can provide
challenges with screening mammography

•

Areas of research include:
● Imaging features differentiating benign and malignant lesions
● How CEUS can influence management of BI-RADS 4 lesions
● Angiogenesis and microvasculature in malignancy
● Evaluation of treatment response to neoadjuvant chemotherapy

Typical imaging features
Qualitative

Quantitative

•

Enhancement pattern

•

Wash-in time

•

Degree of enhancement

•

Area under the curve

•

Enhanced area enlargement?

•

Peak intensity

•

Radial or penetrating vessels?

•

Time-to-peak

•

Margins

•

Ascending slope

[9] Figure 2.

Examples of classic enhancement
patterns
•

Heterogenous
hyperenhancement

•

Enhanced area
enlargement

•

Penetrating vessel

[8]

Examples of classic enhancement
patterns
•

Heterogenous
hyperenhancement

•

Enhanced area
enlargement

•

Penetrating vessel

[8]

Benign patterns

Malignant patterns

Figure 3 [9]

Figure 4 [9]

Tumor microvasculature and
angiogenesis
•

Angiogenesis is an important factor for tumor growth, invasion, and metastatic progression

•

Blood vessel rich peritumoral regions with dilated, large tortuous vessels

•

Intratumoral vessels often naïve, narrow, and obstructed
● Conventional doppler US is not sensitive enough to detect the low-velocity blood flow and small vessel
diameter

•

Microvascular density (MVD)
● Pathologic gold standard for assessment of tumor angiogenesis
● Correlates with histologic grade and proliferative activity
● Independent prognostic factor for breast cancer

Tumor microvasculature and
angiogenesis
•

Specific enhancement patterns and qualitative perfusion parameters are well
correlated with microvascular density and angiogenesis
● Peripheral enhanced lesions had a higher peripheral:central MVD ratio compared to
homogenously enhancing lesions
● Suggests this as a possible indirect prognostic indicator

● Qualitative factors such a peak intensity and area under the curve (AUC) can be
used to detect angiogenesis

Figure 1 [7]

Figure 2 [7]

CEUS and BI-RADS Category 4 lesions
•

BI-RADS Category 4 lesions have a likelihood of malignancy from 2-95%
● Category 4A: > 2% to ≤ 10%
● Category 4B: > 10% to ≤ 50 %
● Category 4C: > 50% to ≤ 95%

•

Category 3 lesions can be managed with short-interval (6 mo.) follow-up while
Category 4 lesions go on to tissue diagnosis

CEUS and BI-RADS Category 4 lesions
•

Conventional ultrasound has a high sensitivity for detection of malignant
lesion, but it has a lower specificity and accuracy

•

Studies have indicated that following certain parameters, CEUS can be used
to:
● Upgrade category 4C lesions to category 5
● Downgrade category 4A lesions to category 3
● Maintain sensitivity

[2]

CEUS in conjunction to other advanced
studies
•

Can be combined with other
advanced ultrasound
techniques
● Shear wave elastography
(SWE)
● Stiffness and increased elasticity
are signs of malignancy
● "Stiff-rim sign"
● When combined with US &
CEUS, significant increases in
specificity, PPV, and accuracy

[8]

CEUS and Treatment Response
•

Early evidence suggesting that CEUS may be an accurate imaging method for
assessing response of breast cancer to neoadjuvant chemotherapy
● Highly reliable contrast agent since it remains intravascular
● Can directly visualize perfusion of the tumor

•

Imaging parameters in early studies not well defined, but encouraging

Figure 2 [4]

Where now?
•

More research and usage is needed outside of Asia

•

Further research into ability to assess treatment response

•

More research into its usefulness in determining tumor extent with possible
implications for surgical resection

Questions?
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Special question for Jihao
What is objectively the coolest ultrasound contrast enhancement pattern?

